Literature DB >> 8642241

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells.

H Xu1, N A DiIulio, R L Fairchild.   

Abstract

Contact hypersensitivity (CHS) is a T cell-mediated response to hapten sensitization of the epidermis. The roles of CD4+ and CD8+ T cells in CHS have remained unclear, however, as studies to define either subset as the T cells mediating CHS have provided conflicting results. The goal of this study was to correlate the in vivo function of CD4+ and CD8+ T cells in CHS with the cytokines produced by each T cell population. Antibody-mediated depletion of CD4+ T cells before sensitization of BALB/c mice with 2,4-dinitrofluorobenzene (DNFB) or oxazolone (Ox) resulted in increased and prolonged CHS responses, indicating CD4+ T cells as negative regulators of the response. Depletion of CD8+ T cells resulted in low or abrogated responses, indicating CD8+ T cells as the effector cells in CHS. Sensitization with DNFB or Ox induced lymph node cell populations of CD8+ T cells producing interferon (IFN)-gamma and no interleukin (Il) 4 or Il-10, and CD4+ T cells producing Il-4 and Il-10 and no or little detectable IFN-gamma. The polarized patterns of cytokine production were stimulated by culture of hapten-primed lymph node cells either on anti-T cell receptor antibody-coated wells or with semipurified Langerhans cells isolated from hapten-sensitized mice. Stimulation of cytokine production during culture of hapten-primed CD4+ or CD8+ T cells with Langerhans cells was hapten specific and restricted to class II or class I major histocompatibility complex, respectively. The induction of the CD4+ and CD8+ T cells producing the polarized patterns of cytokines was not restricted to BALB/c mice, as cells from Ox sensitized C57B1/6 and B10.D2 mice produced the same patterns. Collectively, these results expose the induction of two polarized and functionally opposing populations of T cells by hapten sensitization to induce CHS: IFN-gamma-producing effector CD8+ T cells and Il-4/Il-10-producing CD4+ T cells that negatively regulate the response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642241      PMCID: PMC2192307          DOI: 10.1084/jem.183.3.1001

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines.

Authors:  S Sad; R Marcotte; T R Mosmann
Journal:  Immunity       Date:  1995-03       Impact factor: 31.745

3.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

4.  A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-gamma.

Authors:  R L Coffman; J Carty
Journal:  J Immunol       Date:  1986-02-01       Impact factor: 5.422

5.  NK1.1+ CD4+ CD8- thymocytes with specific lymphokine secretion.

Authors:  H Arase; N Arase; K Nakagawa; R A Good; K Onoé
Journal:  Eur J Immunol       Date:  1993-01       Impact factor: 5.532

6.  Early molecular events in the induction phase of contact sensitivity.

Authors:  A H Enk; S I Katz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

7.  Elicitation of delayed allergic skin reactions with haptens; the dependence of elicitation on hapten combination with protein.

Authors:  H N EISEN; L ORRIS; S BELMAN
Journal:  J Exp Med       Date:  1952-05-01       Impact factor: 14.307

8.  Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.

Authors:  D J Berg; M W Leach; R Kühn; K Rajewsky; W Müller; N J Davidson; D Rennick
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.

Authors:  F P Heinzel; M D Sadick; B J Holaday; R L Coffman; R M Locksley
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

10.  Tumor necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions.

Authors:  P F Piguet; G E Grau; C Hauser; P Vassalli
Journal:  J Exp Med       Date:  1991-03-01       Impact factor: 14.307

View more
  86 in total

Review 1.  Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses.

Authors:  A V Gorbachev; R L Fairchild
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; C Burkhart; A E Cribb; W J Pichler; B K Park
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

3.  A single peripheral CD8+ T cell can give rise to progeny expressing type 1 and/or type 2 cytokine genes and can retain its multipotentiality through many cell divisions.

Authors:  A Kelso; P Groves
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 4.  Polyphenols: skin photoprotection and inhibition of photocarcinogenesis.

Authors:  F Afaq; S K Katiyar
Journal:  Mini Rev Med Chem       Date:  2011-12       Impact factor: 3.862

5.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia.

Authors:  Yaming Wang; Kristy J Szretter; William Vermi; Susan Gilfillan; Cristina Rossini; Marina Cella; Alexander D Barrow; Michael S Diamond; Marco Colonna
Journal:  Nat Immunol       Date:  2012-06-24       Impact factor: 25.606

6.  Proanthocyanidins inhibit UV-induced immunosuppression through IL-12-dependent stimulation of CD8+ effector T cells and inactivation of CD4+ T cells.

Authors:  Mudit Vaid; Tripti Singh; Anna Li; Nandan Katiyar; Samriti Sharma; Craig A Elmets; Hui Xu; Santosh K Katiyar
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-12

7.  CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.

Authors:  Donggou He; Lizhi Wu; Hee Kyung Kim; Hui Li; Craig A Elmets; Hui Xu
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

8.  GLEPP1/protein-tyrosine phosphatase phi inhibitors block chemotaxis in vitro and in vivo and improve murine ulcerative colitis.

Authors:  Rosanna Pescini Gobert; Monique van den Eijnden; Cedric Szyndralewiez; Catherine Jorand-Lebrun; Dominique Swinnen; Linfeng Chen; Corine Gillieron; Fiona Pixley; Pierre Juillard; Patrick Gerber; Caroline Johnson-Léger; Serge Halazy; Montserrat Camps; Agnes Bombrun; Margaret Shipp; Pierre-Alain Vitte; Vittoria Ardissone; Chiara Ferrandi; Dominique Perrin; Christian Rommel; Rob Hooft van Huijsduijnen
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  Bioactive grape proanthocyanidins enhance immune reactivity in UV-irradiated skin through functional activation of dendritic cells in mice.

Authors:  Mudit Vaid; Tripti Singh; Ram Prasad; Craig A Elmets; Hui Xu; Santosh K Katiyar
Journal:  Cancer Prev Res (Phila)       Date:  2013-01-15

10.  Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines.

Authors:  Chun Wang; Jun Yuan; Hua-Xun Wu; Yan Chang; Qing-Tong Wang; Yu-Jing Wu; Li-Hua Liu; Wei Wei
Journal:  Inflamm Res       Date:  2013-10-05       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.